Heyholder
‹ Activism Filings

KMPHARMACEUTICAL Co.,Ltd. Chairman Kang Il Mo group keeps 49.66% stake, fully repays a share-backed loan

KMPHARMACEUTICAL Co.,Ltd.· Report on Large Shareholdings

AI summary · Not investment advice

Kang Il Mo and related parties kept their 49.66% stake in KMPHARMACEUTICAL Co.,Ltd. and fully repaid one share-backed loan. Pledged shares fell from 1,194,503 to 1,100,000; the remaining loan is due 2026.12.04.

Total under contracts

1,100,000 shares

Total 16.96% · previously 18.42%

Key facts

Stake
49.66%Previous 49.66% · 0%p
Reporting holder
Kang Il Mo and 3 related parties
Previous stake
49.66%
Purpose of holding
To influence management
Relationship with issuer
Largest shareholderChairman
Report type
Amendment
Reason for report
Partial repayment of share-backed loans
Previous shares held
3,220,994 shares
Shares held
3,220,994 shares
Reason for amendment
Partial repayment of share-backed loans
Previous shares under major contracts
1,194,503 shares
Shares under major contracts
1,100,000 shares
Reporting obligation date
Sep 30, 2026

Commentary

AI commentary · Not investment advice

What happened

Kang Il Mo, chairman and largest shareholder of KMPHARMACEUTICAL, reported that he fully repaid one of his loans backed by shares (share-backed loans), the one with a securities firm. No shares are pledged under that contract any more. The stake of Kang and his related parties (family and executives counted together) stayed at 49.66%.

In the company's terms

KMPHARMACEUTICAL has 6,485,675 voting shares in issue. The group holds 3,220,994 shares. Pledged shares fell from 1,194,503 (18.42%) to 1,100,000 (16.96%). The remaining pledge secures a KRW 3.4 billion bank loan at 4.34% interest.

What changes for shareholders

The remaining bank loan is due 2026.12.04.

Comments

No comments yet

Comments from shareholders will appear here.